written on 21.05.2014
Tags:
,

Three launches this year just the beginning of Teva turnaround, CEO says

TAGS: ,

Three new drug launches in 2014 won't save Teva's sales if generics attack Copaxone later this week. But they certainly can't hurt.

Latest Report